RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,393 | -57.6% | 37,400 | -49.4% | 0.00% | – |
| Q2 2023 | $95,341 | +105.6% | 73,908 | +110.4% | 0.00% | – |
| Q1 2023 | $46,369 | +6477.2% | 35,128 | +7374.0% | 0.00% | – |
| Q4 2022 | $705 | -85.9% | 470 | -87.0% | 0.00% | – |
| Q3 2022 | $5,000 | -73.7% | 3,627 | -78.0% | 0.00% | – |
| Q2 2022 | $19,000 | -96.9% | 16,506 | -92.0% | 0.00% | – |
| Q1 2022 | $618,000 | -17.6% | 206,948 | -26.9% | 0.00% | – |
| Q4 2021 | $750,000 | -2.2% | 283,190 | +34.2% | 0.00% | – |
| Q3 2021 | $767,000 | -86.7% | 210,986 | -84.1% | 0.00% | -100.0% |
| Q2 2021 | $5,768,000 | +136.3% | 1,329,124 | +86.3% | 0.00% | 0.0% |
| Q1 2021 | $2,441,000 | +68.7% | 713,411 | +72.5% | 0.00% | – |
| Q4 2020 | $1,447,000 | +9.0% | 413,528 | -25.2% | 0.00% | – |
| Q3 2020 | $1,328,000 | -37.5% | 552,907 | -52.4% | 0.00% | -100.0% |
| Q2 2020 | $2,126,000 | +113.2% | 1,161,403 | +81.7% | 0.00% | – |
| Q1 2020 | $997,000 | +42.8% | 639,267 | +96.2% | 0.00% | – |
| Q4 2019 | $698,000 | +2.9% | 325,804 | -10.2% | 0.00% | – |
| Q3 2019 | $678,000 | -29.6% | 362,796 | -1.6% | 0.00% | – |
| Q2 2019 | $963,000 | +33.8% | 368,685 | +31.5% | 0.00% | – |
| Q1 2019 | $720,000 | +239.6% | 280,374 | +203.9% | 0.00% | – |
| Q4 2018 | $212,000 | -24.0% | 92,268 | +6.2% | 0.00% | – |
| Q3 2018 | $279,000 | +13.4% | 86,888 | +0.1% | 0.00% | – |
| Q2 2018 | $246,000 | -21.9% | 86,843 | -2.4% | 0.00% | – |
| Q1 2018 | $315,000 | -7.6% | 89,008 | +1.2% | 0.00% | – |
| Q4 2017 | $341,000 | -67.6% | 87,939 | -78.8% | 0.00% | – |
| Q3 2017 | $1,053,000 | +101.7% | 414,745 | +116.9% | 0.00% | – |
| Q2 2017 | $522,000 | +40.7% | 191,217 | +70.6% | 0.00% | – |
| Q1 2017 | $371,000 | +134.8% | 112,103 | +68.6% | 0.00% | – |
| Q4 2016 | $158,000 | +25.4% | 66,503 | +94.5% | 0.00% | – |
| Q3 2016 | $126,000 | +133.3% | 34,195 | +40.7% | 0.00% | – |
| Q2 2016 | $54,000 | -16.9% | 24,295 | -22.0% | 0.00% | – |
| Q1 2016 | $65,000 | -13.3% | 31,158 | +26.2% | 0.00% | – |
| Q4 2015 | $75,000 | -1.3% | 24,692 | -19.2% | 0.00% | – |
| Q3 2015 | $76,000 | -31.5% | 30,543 | -11.7% | 0.00% | – |
| Q2 2015 | $111,000 | +38.8% | 34,583 | +55.2% | 0.00% | – |
| Q1 2015 | $80,000 | +700.0% | 22,276 | +401.5% | 0.00% | – |
| Q4 2014 | $10,000 | +11.1% | 4,442 | +0.7% | 0.00% | – |
| Q3 2014 | $9,000 | -70.0% | 4,410 | -44.7% | 0.00% | – |
| Q2 2014 | $30,000 | +650.0% | 7,974 | +712.0% | 0.00% | – |
| Q1 2014 | $4,000 | +33.3% | 982 | 0.0% | 0.00% | – |
| Q4 2013 | $3,000 | -50.0% | 982 | -38.8% | 0.00% | – |
| Q3 2013 | $6,000 | +20.0% | 1,604 | 0.0% | 0.00% | – |
| Q2 2013 | $5,000 | – | 1,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |